Market revenue in 2023 | USD 239.9 million |
Market revenue in 2030 | USD 357.3 million |
Growth rate | 5.9% (CAGR from 2023 to 2030) |
Largest segment | Porcine |
Fastest growing segment | Bovine |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Porcine, Bovine |
Key market players worldwide | Pfizer Inc, Sanofi SA, Aspen Pharmacare Holdings Ltd, Fresenius SE & Co KGaA, Novartis AG ADR, GSK PLC ADR, Dr. Reddy’s Laboratories, LEO Pharma, B. Braun Medical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to heparin market will help companies and investors design strategic landscapes.
Porcine was the largest segment with a revenue share of 58.61% in 2023. Horizon Databook has segmented the India heparin market based on porcine, bovine covering the revenue growth of each sub-segment from 2018 to 2030.
The market in India is being driven by factors such as high prevalence of chronic diseases, increase in disposable income, and development of healthcare infrastructure. According to data published in the NCBI, in 2018, India’s epidemiology of CVD has been increasing over the past 2 decades, creating opportunities for market growth.
This is due to a surge in the country’s aging population, an overall high population growth rate, and a stable age-adjusted CVD mortality rate. In addition, the presence of key companies and efforts to execute the Make-inIndia project has attracted various companies, increasing the market potential of heparin in India.
In India, the price of heparin has seen a steep surge since July 2020 and players have increased the ceiling by 50%. It is one of the key drugs being used in ICUs for COVID-19 patients. The price surge is attributable to the increase in API price by 211% since September 2018.
Horizon Databook provides a detailed overview of country-level data and insights on the India heparin market , including forecasts for subscribers. This country databook contains high-level insights into India heparin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account